GAD1 and cancer: Interaction effects between cancer type and time indicated that gynecological cancer patients exhibited a significant reduction in PHQ-9 scores at week 4 (β = −5.84, SE = 2.42, p < 0.05) and in both PHQ-9 (β = −7.58, SE = 3.28, p < 0.05) and GAD-7 scores (β = −5.62, SE = 2.90, p < 0.05) at week 8, as compared to breast cancer patients.